OpenVSafe by OpenVAERS
Search V-safe

2SH-21762-21394

2 vaccinations 8 coded responses 21 check-ins 8 free-text entries 5 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
543 / WI
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2020-12-24
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · None
    Adult check-in
  6. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-30
    Survey response — day 7, dose 1
    MedDRA: Urticaria — Feeling: Good
    Free text: Neck hives. Lasted about three hours then went away without treatment. Did not have anything that would cause this.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-06
    Survey response — day 14, dose 1
    MedDRA: Fatigue — Feeling: Fair
    Free text: Extreme fatigue like I did when I had COVID in September
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-13
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  16. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches
    Adult check-in
  17. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  18. 2021-01-20
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-01-27
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-02-03
    Survey response — day 21, dose 2
    MedDRA: Headache, Lymphadenopathy, Nausea, Night sweats, Vomiting — Feeling: Poor · Be unable to work
    Free text: Nausea. Vomiting. Swollen neck lymph nodes. Headaches. Night sweats.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-10
    Survey response — day 28, dose 2
    MedDRA: Fatigue, Lymphadenopathy, Migraine — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Swollen lymph nodes migraines. Extreme fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-10
    Report sent to call center — day 28, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-02-17
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-02-24
    Survey response — day 42, dose 2
    MedDRA: Disturbance in attention, Fatigue, Migraine, Vertigo — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Migraines. Vertigo. Difficulty concentration Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-04-14
    Survey response — 3 months, dose 2
    MedDRA: Dysmenorrhoea, Fatigue — Feeling: Fair
    Free text: Painful periods . Continued fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-07-14
    Survey response — 6 months, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cyclical (with menses) lymph node swelling since COVID vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-14
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-07-19
  29. 2021-07-20
  30. 2022-01-13
    Survey response — 12 months, dose 2
    MedDRA: Lymphadenopathy, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Recurrent lymph node swelling post vaccine January 2021 · Healthcare visit (other): ID consult
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-13
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-01-14
  33. 2022-01-18
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Call center

5 call center cases

3 successful · 2 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 1 — day 7, dose 1

2020-12-30

Systemic reaction (other): Neck hives. Lasted about three hours then went away without treatment. Did not have anything that would cause this.

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Extreme fatigue like I did when I had COVID in September

Release 3 — day 21, dose 2

2021-02-03

Symptoms: Nausea. Vomiting. Swollen neck lymph nodes. Headaches. Night sweats.

Release 4 — day 28, dose 2

2021-02-10

Symptoms: Swollen lymph nodes migraines. Extreme fatigue.

Release 4 — day 42, dose 2

2021-02-24

Symptoms: Migraines. Vertigo. Difficulty concentration Fatigue

Release 7 — 3 months, dose 2

2021-04-14

Symptoms: Painful periods . Continued fatigue

Release 9 — 6 months, dose 2

2021-07-14

Symptoms: Cyclical (with menses) lymph node swelling since COVID vaccine

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Recurrent lymph node swelling post vaccine January 2021
Healthcare visit (other): ID consult

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDDisturbance in attention ✓ ✓ ✓
SDDysmenorrhoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDNight sweats ✓ ✓ ✓
SDVertigo ✓ ✓ ✓
SDVomiting ✓ ✓ ✓
SROUrticaria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release